📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Strides Pharma Science Ltd
Strides Pharma Science's GHG Emissions Data Preview
In 2023, Strides Pharma Science completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Strides Pharma Science has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Strides Pharma Science’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Strides Pharma Science’s data sources below and access millions more through our Disclosure Search.
Insights into Strides Pharma Science's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions ofStrides Pharma Science amounted to25,553metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Strides Pharma Sciencedecreased by 2.34%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
Strides Pharma Science's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Strides Pharma Science's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Strides Pharma Science were 6,168 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Compared to the previous year(2022), Strides Pharma Science's Scope 1 emissions remained relatively stable, indicating that Strides Pharma Science's emissions have plateaued with no significant change in its operational footprint.a
What are Strides Pharma Science's Scope 2 emissions?
In 2023, Strides Pharma Science reported Scope 2 greenhouse gas (GHG) emissions of 19,385 tCOâ‚‚e without specifying the calculation method.a
Has Strides Pharma Science reduced its Scope 2 emissions over time?
Compared to the previous year(2022), Strides Pharma Science's Scope 2 emissions(Unspecified Calculation Method) have remained relatively stable, indicating that Strides Pharma Science's emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does Strides Pharma Science use for Scope 2 reporting?
In 2023, Strides Pharma Science reported its Scope 2 emissions using an unspecified methodology.a
Strides Pharma Science's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Strides Pharma Science’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Strides Pharma Science reported Scope 1 greenhouse gas (GHG) emissions of 6,168 tCOâ‚‚e and total revenues of USD 439 millions. This translates into an emissions intensity of 14.04 tCOâ‚‚e per millions USD.a
Strides Pharma Science's Scope 1 Emissions Intensity Compared to Peers
How does Strides Pharma Science's GHG emissions intensity compare to its peers?
In 2023, Strides Pharma Science reported a Scope 1 emissions intensity of 14.04 tCOâ‚‚e per millions USD. Compared to the peer group median of 24.05, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does Strides Pharma Science rank on GHG emissions intensity within its industry?
In 2023, Strides Pharma Science ranked 9 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
Strides Pharma Science is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a